FTC sues key pharmacy benefit supervisors over insulin selling prices The agency brought motion against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the record cost of daily life-conserving insulin drugs. Sanders quickly condemned the transfer in a press release Wednesday, noting he https://riverbbbax.tokka-blog.com/30877855/considerations-to-know-about-healthcare-news